0

Impact of Isoflupredone Acetate Treatment on Clinical Signs and Weight Gain in Weanling Heifers With Experimentally Induced Mannheimia Haemolytica Bronchopneumonia

Joanne Hewson, Laurent Viel, Jeff L Caswell, Patricia E Shewen, Jock G Buchanan-Smith

Am J Vet Res. 2011 Dec;72(12):1613-21.

PMID: 22126689

Abstract:

Objective:
To characterize the impact of Mannheimia haemolytica infection on feed intake and weight gain in feedlot heifers and to evaluate the clinical efficacy of isoflupredone acetate administered in combination with oxytetracycline.
Animals:
96 weanling heifers in a research feedlot facility.
Procedures:
Bronchopneumonia was induced by intrabronchial infusion of M haemolytica. Control heifers underwent a sham procedure. Infected heifers were treated with oxytetracycline alone or in combination with isoflupredone acetate (OXY-ISO) or with nothing. Clinical variables were recorded daily for 7 days following disease induction, and feedlot performance indices were measured over a 12-week period.
Results:
Infection caused a reduction in dry-matter intake and average daily gain (ADG) in heifers that received no treatment. Oxytetracycline treatment alone did not prevent reductions in feed intake and ADG during the first week after infection was induced, whereas OXY-ISO treatment did prevent these reductions. Treatment with OXY-ISO also resulted in faster clinical improvement. No significant differences were evident between the oxytetracycline and OXY-ISO groups with respect to dry-matter intake or ADG throughout the study period.
Conclusions and clinical relevance:
Isoflupredone acetate appeared to be a useful clinical adjunct to treatment with oxytetracycline in cattle with acute M haemolytica bronchopneumonia.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP338987 Isoflupredone acetate Isoflupredone acetate 338-98-7 Price
qrcode